Weight gain before and after switch from TDF to TAF in a U.S. cohort study

INTRODUCTION: Although weight gain has been reported with the use of integrase strand transfer inhibitors (InSTI), concurrent use of tenofovir alafenamide (TAF) has been implicated in recent studies. This study examined weight changes in people living with HIV (PLWH) who switched from tenofovir diso...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int AIDS Soc
Main Authors: Mallon, Patrick WG, Brunet, Laurence, Hsu, Ricky K, Fusco, Jennifer S, Mounzer, Karam C, Prajapati, Girish, Beyer, Andrew P, Wohlfeiler, Michael B, Fusco, Gregory P
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8035674/
https://ncbi.nlm.nih.gov/pubmed/33838004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25702
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados